The Scientist

» drug development and immunology

Most Recent

image: FDA OKs siRNA Ebola Drug

FDA OKs siRNA Ebola Drug

By | September 23, 2014

The US Food and Drug Administration gives the green light to deploy an experimental short interfering RNA treatment against Ebola.

0 Comments

image: Ebola Vaccine Protects Macaques

Ebola Vaccine Protects Macaques

By | September 9, 2014

Human trials are now underway.

0 Comments

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

image: FDA to Address Female Sexual Dysfunction

FDA to Address Female Sexual Dysfunction

By | August 15, 2014

The federal agency will convene a two-day workshop in October to discuss the development of drugs to treat the issue.

0 Comments

image: Award-winning Chemist Dies

Award-winning Chemist Dies

By | July 14, 2014

Carlos Barbas III, a renowned organic chemist whose research helped in drug development, passed away at age 49. 

0 Comments

image: Done with Immunosuppressants

Done with Immunosuppressants

By | July 3, 2014

Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.

2 Comments

image: That Loving Feeling

That Loving Feeling

By | July 1, 2014

There are no FDA-approved drugs to treat low sexual desire in women, but not for lack of trying.

1 Comment

image: FDA Approves Another New Antibiotic

FDA Approves Another New Antibiotic

By | June 24, 2014

Second new drug to treat methicillin-resistant Staphylococcus aureus approved under US Food and Drug Administration incentive program. 

1 Comment

image: Protein Clumps Spread Inflammation

Protein Clumps Spread Inflammation

By | June 22, 2014

ASC specks—protein aggregations that drive inflammation—are released from dying immune cells, expanding the reach of a defense response.

1 Comment

image: To Finish Off Polio

To Finish Off Polio

By | June 17, 2014

Along with vaccination, antiviral drugs could play a key role in the eradication of poliovirus, but it’s unclear whether today’s candidate therapies will withstand the challenges of the clinic.

0 Comments

Popular Now

  1. Next Generation: Nanotube Scaffolds Reconnect Spinal Neurons
  2. Mapping the Human Connectome
    Daily News Mapping the Human Connectome

    A new map of human cortex combines data from multiple imaging modalities and comprises 180 distinct regions.

  3. Will Organs-in-a-Dish Ever Replace Animal Models?
  4. Your Office Has a Distinct Microbiome
RayBiotech